Adjuvant chemotherapy in pancreatic cancer

International Journal of Pancreatology

Volumn 21, Issue 1, 1997, Pages 59-63

  Bramhall, Simon R ^a   Neoptolemos, John P ^a,b  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

adjuvant; chemotherapy; Pancreatic cancer; radiotherapy; resection

Indexed keywords

DOXORUBICIN; FLUOROURACIL; MITOMYCIN C;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; HUMAN; PANCREAS CANCER; PRIORITY JOURNAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; HUMANS; PANCREATIC NEOPLASMS;

EID: 0030897883     PISSN: 01694197     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Tepper J, Nardi G, Suit H. Carcinoma of the pancreas: review of MGH experience from 1963 to 1973. Cancer 1976; 37: 1519-1524.
2. Griffin JF, Smalley SR, Paradelo JC, Reymond RD, Jewell W, Holsavier RES, Evans RG. Patterns of failure after curative resection of pancreatic carcinoma. Cancer 1990; 66(1): 56-61.
3. Whittington R, Bryer MP, Haller DG, Solin LJ, Rosato EF. Adjuvant therapy of resected adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys 1991; 21(5): 1137-1143.
4. Menke-Ploymers MB, Klinkenbijl JH, Tjioe M, Jeekel J. Treatment of locoregional recurrence after intentional curative resection of pancreatic cancer. Hepatogastroenterology 1992; 39(5): 429-432.
5. Westerdahl J, Andren-Sandberg A, Ihse I. Recurrence of exocrine pancreatic cancer - local or hepatic? Hepatogastroenterology 1993; 40(4): 384-387.
6. Kayahara M, Nagakawa T, Ueno K, Ohta T, Takeda T, Miyazaki I. An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging. Cancer 1993; 72(7): 2118-2123.
7. Arbuck SG. Chemotherapy for pancreatic cancer. Baillieres Clin Gastroenterol 1990; 4(4): 953-968.
8. Mallinson CN, Rake MD, Cocking JB, Fox CA, Gwynarski MT, Diffey BL, Jackson GA, Hanley J, Wass VJ. Chemotherapy in pancreatic cancer: results of a controlled prospective randomised multicentre trial. Br Med J 1980; 281: 1589-1591.
9. Palmer KR, Kerr M, Knowles G, Cull A, Carter DC, Leonard RC. Chemotherapy prolongs survival in inoperable pancreatic carcinoma. Br J Surg 1994; 81(6): 882-885.
10. Cullinan S, Moertel CG, Wieand HS, Schutt AJ, Krook JE, Foley JF, Norris BD, Kardivol CG, Tschetter LK, Barlow JF. A phase III trial on the therapy of advanced pancreatic carcinoma. Evaluations of the Mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin. Cancer 1990; 65(10): 2207-2212.
11. Moertel CG, Childs DS, Reitermeier RJ, Colby MY, Holbrook MA. Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet 1969; 2: 865-867.
12. Gastrointestinal Tumour Study Group. Therapy of locally unresectable pancreatic carcinoma: a randomised comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000rads+5-fluorouracil), and high dose radiation + 5-fluorouracil. Cancer 1981; 48(8): 1705-1710.
13. Moertel CG, Gunderson LL, Mailliard JA, McKenna PS, Martenson JA, Burch PA, Chu SS. Early evaluation of combined fluorouracil and leucovorin as a radiation enhancer for locally unresectable, residual, or recurrent gastrointestinal carcinoma. The North Central Cancer Treatment Group. J Clin Oncol 1994; 12(1): 21-27.
14. Klaasen DJ, MacIntyre IM, Catton GE, Engstrom PF, Moertel CG. Treatment of locally unresectable cancer of the stomach and pancreas: a randomised comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance of 5-fluorouracil. An Eastern Cooperative Oncology Group Study. J Clin Oncol 1985; 3: 373-378.
15. Gastrointestinal Tumour Study Group. Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. J Natl Cancer Inst 1988; 80: 751-757.
16. Splinter TA, Obertop H, Kok TC, Jeekel J. Adjuvant chemotherapy after resection of adenocarcinoma of the periampullary region and the head of the pancreas. A non-randomized pilot study. J Cancer Res Clin Oncol 1989; 115(2): 200-202.
17. Livingston EH, Welton ML, Reber HA. Surgical treatment of pancreatic cancer. The United States experience. Int J Pancreatol 1991; 9: 153-157.
18. Bakkevold KE, Arnesio B, Dahl O, Kambestad B. Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater - results of a controlled, prospective, randomised multicentre study. Eur J Cancer 1993; 5: 698-703.
19. Baumel H, Huguier M, Manderscheid JC, Fabre JM, Houry S, Fagot H. Results of resection for cancer of the exocrine pancreas: a study from the French Association of Surgery. Br J Surg 1994; 81(1): 102-107.
20. Gastrointestinal Tumour Study Group. Phase II studies of drug combinations in advanced pancreatic carcinoma: fluorouracil plus doxorubicin plus mitomycin-C and two regimens of streptozocin plus mitomycin-C plus fluorouracil. J Clin Oncol 1986; 4: 1794-1798.
21. Oster MW, Gray R, Panasci L, Perry MC. Chemotherapy for advanced pancreatic cancer: a comparison of 5-Fluorouracil, Adriamycin, and Mitomycin (FAM) with 5-Fluorouracil, Streptozotocin, and Mitomycin (FSM). Cancer 1986; 57(1): 29-33.
22. Kalser MH, Ellenberg SS. Pancreatic cancer: adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 1985; 120: 899-903.
23. Gastrointestinal Tumour Study Group. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 1987; 59(12): 2006-2010.
24. Ozaki H, Kinoshita T, Kosuge T, Egawa S, Kishi K. Effectiveness of multimodality treatment for resectable pancreatic cancer. Int J Pancreatol 1990; 7(1-3): 195-200.